Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on: December 22,2023

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on:December 22,2023

Five facts you may not know about brain tumors

by Laura Hegwer,Rush University Medical CenterCredit: Unsplash/CC0 Public DomainBrain tumors scare most people, but there are still reasons to be hopeful if you learn you have an abnormal growth

Updated on: December 23,2023

Five facts you may not know about brain tumors

by Laura Hegwer,Rush University Medical CenterCredit: Unsplash/CC0 Public DomainBrain tumors scare most people, but there are still reasons to be hopeful if you learn you have an abnormal growth

Updated on:December 23,2023

Early disease detection in body fluids using photonic biosensors

by Anne-Julie Zichner, Fraunhofer-Institut für Photonische Mikrosysteme (IPMS)Photonic biosensor chip of Fraunhofer IPMS Credit: Fraunhofer IPMSStandard medical procedures are often time-consuming and

Updated on: August 08,2024

Early disease detection in body fluids using photonic biosensors

by Anne-Julie Zichner, Fraunhofer-Institut für Photonische Mikrosysteme (IPMS)Photonic biosensor chip of Fraunhofer IPMS Credit: Fraunhofer IPMSStandard medical procedures are often time-consuming and

Updated on:August 08,2024

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m

Updated on: October 24,2023

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m

Updated on:October 24,2023

New gene target for aggressive lung cancer discovered

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of sm

Updated on: December 22,2023

New gene target for aggressive lung cancer discovered

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of sm

Updated on:December 22,2023

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples

Updated on: December 26,2023

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples

Updated on:December 26,2023

Health Disparities Persist in Hemophilia Life Expectancy

January 2024Lara C. Pullen, PhDBetween 1999 and 2020, recorded hemophilia death (rHD) rates in the U.S. improved in males across all racial and ethnic groups.Stacey A. Fedewa, PhD, MPH,of

Updated on: February 18,2024

Health Disparities Persist in Hemophilia Life Expectancy

January 2024Lara C. Pullen, PhDBetween 1999 and 2020, recorded hemophilia death (rHD) rates in the U.S. improved in males across all racial and ethnic groups.Stacey A. Fedewa, PhD, MPH,of

Updated on:February 18,2024

Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of more than 1 million people has found that most persons screened for lung cancer meet U.S. Preventative Services

Updated on: December 20,2023

Most persons screened for lung cancer meet USPSTF criteria, but adherence to follow-up screening low

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study of more than 1 million people has found that most persons screened for lung cancer meet U.S. Preventative Services

Updated on:December 20,2023

Decrease noted in lung cancer cases over past five years

by Elana Gotkine HealthDay ReporterThe number of new cases of lung cancer has decreased over the last five years, but screening rates are still low, according to a report published by the American Lun

Updated on: December 23,2023

Decrease noted in lung cancer cases over past five years

by Elana Gotkine HealthDay ReporterThe number of new cases of lung cancer has decreased over the last five years, but screening rates are still low, according to a report published by the American Lun

Updated on:December 23,2023

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Updated on: December 22,2023

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Updated on:December 22,2023

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

In a recent study published in the journalAntioxidants, researchers discuss the potential role of melatonin in regulating deoxyribonucleic acid (DNA) methylation.Study:Melatonin: A P

Updated on: October 28,2023

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

In a recent study published in the journalAntioxidants, researchers discuss the potential role of melatonin in regulating deoxyribonucleic acid (DNA) methylation.Study:Melatonin: A P

Updated on:October 28,2023

Talquetamab Adverse Event Management in Myeloma Requires Early Oral, Dermatologic Interventions

August 25, 2022Lindsay FischerPatients with multiple myeloma can mitigate the common oral and dermatologic toxicities associated with talquetamab with early intervention tactics.Effective methods of m

Updated on: October 24,2023

Talquetamab Adverse Event Management in Myeloma Requires Early Oral, Dermatologic Interventions

August 25, 2022Lindsay FischerPatients with multiple myeloma can mitigate the common oral and dermatologic toxicities associated with talquetamab with early intervention tactics.Effective methods of m

Updated on:October 24,2023